Tohoku University Technology: New Lactobacillus strain that enhance immune activity: T19-816
Protect human and animals from viruses by Immunobiotics
Rotavirus is a major cause of acute enteritis in infants and young livestock. It kills 500,000 people per year, mainly in developing countries, and also causes enormous economic losses to livestock production. Inventors focus on immunobiotics and found that new Ligilactobacillus and Lactiplantibacillus strains enhance anti-viral immune activity. ・Isolation of several anti-virus immune-enhancing Ligilactobacillus and Lactiplantibacillus strains from the small intestine of Wakame-fed pigs. ・These strains are deposited in NITE in Japan.
Inquire About This Product
basic information
For details, please contact us or refer to the PDF.
Price range
Delivery Time
Applications/Examples of results
For details, please contact us or refer to the PDF.
catalog（1）
Download All Catalogs
Company information
The revenue generated from technology transfer is reinvested into universities and researchers as new research funding, which is used to create further research outcomes. To ensure the smooth operation of this cycle, known as the "Intellectual Creation Cycle," we will actively promote technology transfer. The types of seeds we handle include patents, know-how, databases, and programs. We have established a collaborative framework by concluding basic technology transfer agreements with the following universities (as of June 1, 2025): - Tohoku University - Hirosaki University - Iwate University - Akita University - Fukushima University - Yamagata University - Tohoku Gakuin University - Iwate Medical University - Fukushima Medical University - Aizu University - Miyagi University - Hokkaido University - Muroran Institute of Technology - Showa Medical University
